摘要
中国生化制药工业协会多肽分会日前召开多肽药物专家共识研讨会,专家们就中国多肽药物发展现状,发展重点方向及对相关部门的建议达成共识。
The experts of peptide medicine reached a consensus about Chinese peptide medicine present development status,important development direction,existing problems and suggestions at the conference of China Biochemical Pharmaceutical Industry Association Peptide Chapter on January 3,2020.
出处
《药物生物技术》
CAS
2020年第1期14-16,共3页
Pharmaceutical Biotechnology
关键词
多肽药物
中国生化制药工业协会多肽分会
专家共识
Peptide medicine
China Biochemical Pharmaceutical Industry Association Peptide Chapter
Expert consensus
